Skip to main content

Marvin Slepian, MD, JD

Regents Professor of Medicine, Medical Imaging, Engineering, Materials Science & Engineering and Biomedical Engineering
Director, Arizona Center for Accelerated Biomedical Innovation
slepian@arizona.edu

Instrumental in formation of SynCardia Systems, Inc., maker of the CardioWest Temporary Total Artificial Heart (TAH-t) Polymer Chemistry, Assisted Devices. In 2009, Dr Slepian was appointed chairman of the Science Advisory Board for MicroMed Cardiovascular, manufacturer of the HeartAssist 5™ ventricular assist device. The CardioWest (trademarked) TAH-t completely replaces the blood-pumping function of the diseased heart. For patients with end-stage congestive heart failure at imminent risk of death, this device has proven to be a life-saver, allowing them to be “bridged” and supported until a human heart transplant can be performed. He is recognized for his research and development of novel therapeutics. These include the use of polymeric biomaterials as tissue supports, barriers or means of local drug delivery in tubular organs or organ components, biodegradable stents, drug-eluting stents and the TAH.

The Arizona Board of Regents appointed Marvin Slepian, MD, a Regents Professor in 2019.

The UA College of Engineering named Dr. Slepian a DaVinci Fellow. The award recognizes talented and resourceful faculty and provides a one-time grant of $10,000. Dr. Slepian plans to use the funds to support student research in his lab.

Watch Monitoring Blood Pressure with Wearable Technology.

Degrees

  • MD: University of Cincinnati College of Medicine, 1981
  • JD: University of Arizona James E. Rogers College of Law
Residency
New York University Bellevue Hospital, Internal Medicine, 1985
Fellowship
Johns Hopkins University, Cardiology
Honors and Awards
McGuire Scholar, Eller College of Management
University of Cincinnati College of Medicine, Daniel Drake Award (for distinguished alumni)